
aug pm et
summari compani one largest world-wide provid integr dialysi servic
patient suffer chronic kidney failur
price-to-earnings oper ep
risk assess reflect stabl demand dialysi
servic driven rise senior popul
off-set depend third-parti payment
includ medicar medicaid
nov ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
aug pm stock trade
expect net revenu declin
primarili divestitur
davita medic group dmg segment
expect net revenu increas
long-term growth driver
includ age popul
number dialysi facil
oper howev intern oper
like gener oper loss
next year expand presenc
abroad gain scale dialysi busi
face could continu face
headwind declin payor mix toward
medicar medicaid less
profit commerci insur
forecast oper margin
primarili dmg divestitur
margin headwind includ lower
cost regulatori activ long
term margin like enhanc
oper effici gain open
new dialysi facil
estim ep vs
realiz
recommend hold mani year
flat rate medicar propos lift
dialysi reimburs posit
also see long-term grow trend
diabet obes posit
trend like sustain demand
dialysi servic think
pend sale dmg segment
allow focu core
busi increas financi flexibl
transact expect close
august two
regulatori overhang could potenti
materi california ballot initi
implement profit cap dialysi provid
propos bill sb would limit
econom benefit charit premium
assist overal except
hard-to-predict regulatori overhang think
share price mostli reflect
risk recommend target price
unfavor chang medicar medicaid
reimburs weaker-than-expect
target price appli
line peer ev forward ebitda multipl
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview davita inc lead provid dialysi relat servic patient
suffer chronic kidney failur also known end-stag renal diseas esrd decemb
compani oper provid administr servic network outpati
dialysi center design specif outpati hemodialysi
result growth acquisit occasion becom highli leverag
opinion acquir center gambro acquisit well independ
center compani acquir center open new center sold six close
septemb acquir dsi renal ad facil led divestitur mani
dsi portfolio novemb complet merger privately-held healthcar partner
physician practic network billion payabl billion cash million share
decemb enter agreement sell davita medic group collabor
hold subsidiari billion cash sale expect close
improv compani financi flexibl
hemodialysi use artifici kidney call dialyz remov certain toxin fluid salt
patient blood togeth machin control extern blood flow monitor certain vital sign
patient periton dialysi use patient periton abdomin caviti elimin fluid
market profil esrd state advanc renal impair irrevers requir routin
dialysi treatment kidney transplant sustain life treatment option esrd includ
hemodialysi periton dialysi kidney transplant growth procedur driven
age popul increas incid rate diseas caus kidney failur
diabet hypertens lower mortal rate dialysi patient growth rate minor
popul higher-than-averag incid rate esrd assum dialysi market
 continu grow mid-singl digit rang next sever year age
popul keep long-term growth mid-singl digit rang
legal/regulatori issu govern medicar medicaid remain primari
payor care esrd dialysi patient account roughli two-third dialysi revenu
medicar account major govern revenu balanc deriv
commerci payor esrd payment rate dialysi establish congress medicar composit
rate set center medicar medicaid servic includ payment dialysi
treatment suppli use treatment specifi laboratori test certain pharmaceut
provid paid separ servic pharmaceut includ erythropoietin epo
vitamin analog iron supplement gener averag cost servic pharmaceut
plu small margin base price set medicar medicar payment rate suffici
cover averag cost provid dialysi treatment
cover treatment medicar pay amount set medicar system patient
respons remain case secondari payor cover part
financi trend averag revenu per treatment
level volatil recent year due fluctuat patient mix
commerci govern insur patient go forward expect revenu growth mid-
upper singl digit ep growth low-doubl digit expand oper
domest intern address medicar reimburs cut may berkshir
hathaway took stake agre standstil agreement acquir
stake decemb berkshir stake septemb
complet stock split rais number share outstand million
offic intern
presid
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
under-valued
bullish sinc august technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
success elimin individu
mandat passag tax cut
job act decemb see
develop neg health care
servic provid fewer custom like
enrol insur plan start
fewer patient insur uncompens
care rate could rise hospit
facil lead lower profit
lower demand supplement health care
year date june
versu increas
composit index health
servic increas vs
increas composit index
fundament outlook health care
servic sub-industri next month
neutral think servic includ
rehabilit clinic laboratori
dialysi continu benefit
trend continu pressur
trump administr reduc govern
spend turn rais
possibl medicar reimburs rate
cut repeal afford act
rollback medicaid expans
expect provid servic dialysi
rehabilit center see mix
util increas drug price
servic provid must maintain commerci
custom base uphold profit level
custom pay higher rate
medicar
think age popul
increas focu prevent care
benefit clinic lab addit expect
increas number test per
requisit esoter test could lead
low-single-digit sale growth lab
lower outlook pharmaci benefit
manag pbm posit neutral
see lower level drug price inflat hurt
growth still high util
also see pbm continu benefit
mani brand drug lost patent
protect recent year increas
gener drug usag would increas
profit pbm
although republican administr
 difficulti repeal
stop medicaid expans think
repeal question
senat fail multipl time gather
suffici number vote pass variou
repeal replac bill howev republican
base index
five-year market price perform aug
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
multipl estim line peer balanc stabl sale
growth outlook expect margin compress lower
reimburs rate partial off-set cost reduct effort trim
ep estim report
oper ep vs consensu sale increas
growth medic segment expect sale growth
aid modest volum increas /keith snyder
keep target appli ev/ebitda multipl
estim slight discount five-year
histor averag reflect slow long-term sale earn
growth outlook keep ep estim trim
report oper ep
vs consensu total sale increas driven
growth medic group segment expect sale growth
volum growth partial off-set declin
rais target ev/ebitda
multipl estim discount peer reflect
slower revenu growth outlook trim ep
estim report oper
ep vs consensu sale increas
increas treatment volum see sale growth
impact reimburs rate pressur given limit
visibl due regulatori uncertainti surround futur
maintain hold opinion /k snyder
et capit iq maintain hold opinion share
inc keep target
ep estim multipl discount three-year
histor averag price-to-earnings reflect expect modest margin
compress higher cost cut ep estim
set report oper ep
vs capit iq consensu net revenu increas
driven growth medic group expect signific declin
number dialysi patient cover due soft overal
enrol exchang /k snyder
analyst research note compani news
lift target base total
enterpris valu ev ebitda ratio in-lin
peer ep vs higher estim lower
ep ep sale
increas billion total dialysi treatment grew
year-over-year revenu per treatment slightli well
adjust medicar bad debt recoveri manag note
two regulatori overhang could materi california ballot
initi implement profit cap dialysi provid propos bill
sb would limit econom benefit charit premium assist
adjust oper margin declin
wage price pressur outweigh cost contain effort
et cfra maintain hold opinion share inc
keep target price appli ev/ebitda
multipl estim slight discount peer averag
reflect slow revenu growth outlook regulatori headwind rais
ep estim trim
report oper ep vs consensu
revenu increas aid increas number treatment
per day growth revenu per treatment see oper margin
expand driven pend sale davita medic group
segment expect declin sale due segment sale
growth modest increas volum revenu per treatment
rais target price appli
ev/ebitda multipl estim line peer
balanc reimburs rate pressur expect benefit
sale medic group segment increas ep estim
set report oper ep
vs line consensu sale increas aid
growth treatment per day expect experi margin pressur
driven increas labor cost flat reimburs rate /keith
et cfra keep buy opinion share group
agre acquir davita medic group physician
group believ deal fit well
strategi expand optum unit includ primari
urgent ambulatori care davita medic oper clinic urgent
care center half-dozen outpati surgic center medic staff
six state see million patient note unit post
loss think leverag overlap certain area
includ cost synergi improv unit profit /jeffrey
et cfra keep hold opinion share inc
enter definit agreement
sell davita medic group dmg segment billion cash dmg
oper nearli clinic well urgent care center six
outpati surgic center pend transact subject regulatori
approv customari close condit expect close
see pend deal posit allow focu
core kidney dialysi busi increas financi flexibl
buyback de-lever strateg opportun /danni yang
maintain target price appli ev/ebitda
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
